Zobrazeno 1 - 1
of 1
pro vyhledávání: '"53"'
Autor:
Ahmed M. Soliman, Andrew J. K. Östör, Ann Eldred, Wenjing Lu, Ricardo Blanco, Jacob A. Aelion, Lisa Barcomb, Alan Kivitz, Zailong Wang, Kim A. Papp, Cecilia Asnal, Filip Van den Bosch, Gabriela Alperovich
Publikováno v:
ANNALS OF THE RHEUMATIC DISEASES
ObjectivesRisankizumab is an interleukin-23 inhibitor under study for the treatment of patients with psoriatic arthritis (PsA). The phase 3 KEEPsAKE 2 trial investigated the efficacy and safety of risankizumab versus placebo in patients with active P